Yasuhiro Tsutani

Researcher Name Resolver ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Topics

Sentinel Lymph Node

Positron Emission Tomography

Small Cell Lung Cancer

Top Venues

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Thoracic cancer

Japanese journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yasuhiro Tsutani, Yoshihiro Miyata, Kenji Suzuki, Fumihiro Tanaka, Hiroyuki Ito, Yoshinori Yamashita, Morihito Okada
Pathologic Response and Survival after Neoadjuvant Chemotherapy with Bevacizumab Followed by Surgery for Clinical Stage II/IIIA Nonsquamous Non-Small-Cell Lung Cancer: Results from a Phase II Feasibility Study (NAVAL). Cancers 16 (13) (2024)
Yu Izaki, Takahiro Mimae, Atsushi Kagimoto, Yoshinori Handa, Yasuhiro Tsutani, Yoshihiro Miyata, Morihito Okada, Yukio Takeshima
Differences in postoperative prognosis between early-stage lung adenocarcinoma and squamous cell carcinoma. Japanese journal of clinical oncology (2024)
Kazuo Nakagawa, Masaya Yotsukura, Takahiro Mimae, Aritoshi Hattori, Tomohiro Miyoshi, Mitsuhiro Isaka, Makoto Endo, Yasuhiro Tsutani, Tetsuya Isaka, Tomohiro Maniwa, Ryu Nakajima, Hiroshige Yoshioka, Hidefumi Takei, Keiju Aokage, Shun-Ichi Watanabe
The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: outstanding contribution and entering a new phase. Japanese journal of clinical oncology (2024)
Yu Izaki, Takahiro Mimae, Atsushi Kagimoto, Yoshinori Handa, Yasuhiro Tsutani, Yoshihiro Miyata, Morihito Okada, Yukio Takeshima
Differences in postoperative prognosis between early-stage lung adenocarcinoma and squamous cell carcinoma. Japanese journal of clinical oncology 54 (7) (2024)
Yasuhiro Tsutani, Yoshihiro Miyata, Kenji Suzuki, Fumihiro Tanaka, Hiroyuki Ito, Yoshinori Yamashita, Morihito Okada
Pathologic Response and Survival after Neoadjuvant Chemotherapy with Bevacizumab Followed by Surgery for Clinical Stage II/IIIA Nonsquamous Non-Small-Cell Lung Cancer: Results from a Phase II Feasibility Study (NAVAL). Cancers 16 (13) (2024)
Shota Fukuda, Kenichi Suda, Akira Hamada, Hana Oiki, Shuta Ohara, Masaoki Ito, Junichi Soh, Tetsuya Mitsudomi, Yasuhiro Tsutani
Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms-An In Vitro Study. Biomedicines 12 (7) (2024)
Shota Fukuda, Kenichi Suda, Akira Hamada, Hana Oiki, Shuta Ohara, Masaoki Ito, Junichi Soh, Tetsuya Mitsudomi, Yasuhiro Tsutani
Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms-An In Vitro Study. Biomedicines 12 (7) (2024)
Shota Fukuda, Kenichi Suda, Akira Hamada, Hana Oiki, Shuta Ohara, Masaoki Ito, Junichi Soh, Tetsuya Mitsudomi, Yasuhiro Tsutani
Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms-An In Vitro Study. Biomedicines 12 (7) (2024)
Shota Fukuda, Kenichi Suda, Akira Hamada, Yasuhiro Tsutani
Recent Advances in Perioperative Immunotherapies in Lung Cancer. Biomolecules 13 (9) (2023)
Kenichi Suda, Kazuko Sakai, Tatsuo Ohira, Takaaki Chikugo, Takao Satou, Jun Matsubayashi, Toshitaka Nagao, Norihiko Ikeda, Yasuhiro Tsutani, Tetsuya Mitsudomi, Kazuto Nishio
Performance of Ultra-Rapid Idylla™ EGFR Mutation Test in Non-Small-Cell Lung Cancer and Its Potential at Clinical Molecular Screening. Cancers 15 (9) (2023)
Nobutaka Kawamoto, Yasuhiro Tsutani, Morihito Okada
Reply to Sanz-Santos et al. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 63 (3) (2023)
Kenichi Suda, Kazuko Sakai, Tatsuo Ohira, Takaaki Chikugo, Takao Satou, Jun Matsubayashi, Toshitaka Nagao, Norihiko Ikeda, Yasuhiro Tsutani, Tetsuya Mitsudomi, Kazuto Nishio
Performance of Ultra-Rapid Idylla™ EGFR Mutation Test in Non-Small-Cell Lung Cancer and Its Potential at Clinical Molecular Screening. Cancers 15 (9) (2023)
Nobutaka Kawamoto, Yasuhiro Tsutani, Atsushi Kamigaichi, Manato Ohsawa, Takahiro Mimae, Yoshihiro Miyata, Morihito Okada
Tumour location predicts occult N1 nodal metastasis in clinical stage I non-small-cell lung cancer. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 63 (2) (2023)
Yoshinori Handa, Yasuhiro Tsutani, Takahiro Mimae, Yoshihiro Miyata, Hiroyuki Ito, Yoshihisa Shimada, Haruhiko Nakayama, Norihiko Ikeda, Morihito Okada
A multicenter propensity score-matched analysis of lymphadenectomy in N1-positve lung cancer. Japanese journal of clinical oncology (2023)
Atsushi Kamigaichi, Yasuhiro Tsutani, Takahiro Mimae, Yoshihiro Miyata, Yoshihisa Shimada, Hiroyuki Ito, Haruhiko Nakayama, Norihiko Ikeda, Morihito Okada
The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 62 (3) (2022)
Atsushi Kagimoto, Yasuhiro Tsutani, Kei Kushitani, Takahiro Kambara, Takahiro Mimae, Yoshihiro Miyata, Yukio Takeshima, Morihito Okada
Usefulness of serum S100A4 and positron-emission tomography on lung cancer accompanied by interstitial pneumonia. Thoracic cancer 14 (4) (2022)
Atsushi Kagimoto, Yasuhiro Tsutani, Yoshihisa Shimada, Takahiro Mimae, Yoshihiro Miyata, Hiroyuki Ito, Haruhiko Nakayama, Norihiko Ikeda, Morihito Okada
Segmentectomy for clinically early-stage primary squamous cell carcinoma of the lung. Thoracic cancer (2022)
Takahiro Mimae, Yoshihiro Miyata, Takashi Kumada, Yoshinori Handa, Yasuhiro Tsutani, Morihito Okada
Interstitial pneumonia and advanced age negatively influence postoperative pulmonary function. Interactive cardiovascular and thoracic surgery 34 (5) (2022)
Atsushi Kagimoto, Yasuhiro Tsutani, Kei Kushitani, Takahiro Kambara, Takahiro Mimae, Yoshihiro Miyata, Yukio Takeshima, Morihito Okada
Usefulness of serum S100A4 and positron-emission tomography on lung cancer accompanied by interstitial pneumonia. Thoracic cancer 14 (4) (2022)
Atsushi Kagimoto, Yasuhiro Tsutani, Kei Kushitani, Takahiro Kambara, Takahiro Mimae, Yoshihiro Miyata, Yukio Takeshima, Morihito Okada
Usefulness of serum S100A4 and positron-emission tomography on lung cancer accompanied by interstitial pneumonia. Thoracic cancer (2022)
Atsushi Kagimoto, Yasuhiro Tsutani, Yoshihisa Shimada, Takahiro Mimae, Yoshihiro Miyata, Hiroyuki Ito, Haruhiko Nakayama, Norihiko Ikeda, Morihito Okada
Oncological outcome of segmentectomy for early-stage non-small-cell lung cancer with invasive characteristics: a multicentre study. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 62 (2) (2022)
Atsushi Kagimoto, Yasuhiro Tsutani, Takahiro Mimae, Yoshihiro Miyata, Morihito Okada
Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer. Interactive cardiovascular and thoracic surgery 34 (5) (2022)
Atsushi Kagimoto, Yasuhiro Tsutani, Morihito Okada
Reply to Zhou et al. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 62 (4) (2022)
Atsushi Kagimoto, Yasuhiro Tsutani, Takahiro Mimae, Yoshihiro Miyata, Norihiko Ikeda, Hiroyuki Ito, Yoshimasa Maniwa, Kenji Suzuki, Masahiro Tsuboi, Kenichi Yoshimura, Seiji Umemoto, Morihito Okada
Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL). BMJ open 11 (3) (2021)
Atsushi Kagimoto, Yasuhiro Tsutani, Takahiro Mimae, Yoshihiro Miyata, Morihito Okada
Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2021)
Masaoki Ito, Yoshihiro Miyata, Kei Kushitani, Atsushi Kagimoto, Daisuke Ueda, Yasuhiro Tsutani, Yukio Takeshima, Morihito Okada
Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size. Thoracic cancer 12 (23) (2021)
Yuta Ibuki, Yukie Nishiyama, Yasuhiro Tsutani, Manabu Emi, Yoichi Hamai, Morihito Okada, Hidetoshi Tahara
Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma. PloS one 15 (4) (2020)
Yumiko Koi, Yasuhiro Tsutani, Yukie Nishiyama, Daisuke Ueda, Yuta Ibuki, Shinsuke Sasada, Tomoyuki Akita, Norio Masumoto, Takayuki Kadoya, Yuki Yamamoto, Ryou-U Takahashi, Junko Tanaka, Morihito Okada, Hidetoshi Tahara
Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles. Cancer science 111 (6) (2020)
Yumiko Koi, Yasuhiro Tsutani, Yukie Nishiyama, Miyuki Kanda, Yoshitomo Shiroma, Yuki Yamamoto, Shinsuke Sasada, Tomoyuki Akita, Norio Masumoto, Takayuki Kadoya, Ryou-U Takahashi, Junko Tanaka, Morihito Okada, Hidetoshi Tahara
Diagnostic performance of peripheral leukocyte telomere G-tail length for detecting breast cancer. Cancer science 111 (5) (2020)
Yasuhiro Tsutani, Yoshihiro Miyata, Takeshi Masuda, Kazunori Fujitaka, Mihoko Doi, Yoshikazu Awaya, Shoichi Kuyama, Soichi Kitaguchi, Kazuhiro Ueda, Noboru Hattori, Morihito Okada
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study. BMC cancer 18 (1) (2018)